TS 2010 Annual Meeting

Print this page

Add to Outlook

Tell a Colleague

Add Bookmark

Meeting Program

(information subject to change)

Saturday, June 26, 2010

7:00 AM–6:00 PM	Registration—Marriott Ballroom VI Foyer

7:30 AM–8:00 AM	Education Course, Coffee and Continental Breakfast—Marriott Ballroom VI

8:00 AM–11:30 AM	Education Course Session 1 (Separate registration required) —Marriott Ballroom VI Prenatal Drug Disposition and Teratogenesis
	Organized by the Education Committee, Chairperson, Louise M. Winn, Queen’s University

8:00 AM–8:10 AM	Welcome
	Barbara F. Hales, Teratology Society President

8:10 AM–8:15 AM	Course Overview
	Education Committee Chairperson, Louise M. Winn, Queen’s University

8:15 AM–9:00 AM	The Role of Biotransformation in Developmental Toxicology
	Craig Harris, University of Michigan

9:00 AM–9:45 AM	Stage- and Species-Specific Disposition of Toxicants during Pregnancy
	Edward W. Carney, The Dow Chemical Company

9:45 AM–10:00 AM	Break

10:00 AM–10:45 AM	Prenatal Ontogeny and Capabilities of Phase I and Phase II Enzymes
	J. Steven Leeder, Children's Mercy Hospitals and Clinics

10:45 AM–11:30 AM	Repair Capabilities in the Embryo
	Peter G. Wells, University of Toronto

11:30 AM–1:30 PM	Lunch on Your Own

12:00 NOON–1:00 PM	F. CLARKE Fraser and Service Awards Committee Meeting—Skybox Meeting Room

12:30 PM–5:30 PM	TS/OTIS Pregnancy Registry Workshop—Marriott Ballroom IX
	Moderators: Christina D. Chambers, University of California, San Diego and Lewis B. Holmes, MassGeneral Hospital For Children

12:30 PM–12:40 PM	Introduction

12:40 PM–1:10 PM	Classifying Birth Defects in Reproductive Research
	Lewis B. Holmes, MassGeneral Hospital for Children

1:10 PM–1:50 PM	Point/Counterpoint

1:10 PM–1:30 PM	Methodological Challenges in Surveillance of Spontaneous Abortion As a Reproductive Health Endpoint David A. Savitz, Mt. Sinai School of Medicine

1:30 PM–1:50 PM	Studying Miscarriage Using Pregnancy Registries De-Kun Li, Kaiser Permanente Medical Group

1:50 PM–2:10 PM	Organizing Pregnancy Registries during an Emergency Response
	Ava Marie S. Conlin, Naval Health Research Center

2:10 PM–2:30 PM	The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS): Launch of a New System for Post-Marketing Surveillance
	Christina Chambers, University of California, San Diego

2:30 PM–3:15 PM	Panel Discussion: FDA Pregnancy Registry Guidance Document Revisions
	Moderator: Melissa S. Tassinari, U.S. Food and Drug Administration

3:15 PM–3:30 PM	Universal Call Center for Medicine Use in Pregnancy
	Michael McDonagh, CKR Consulting

3:30 PM–3:45 PM	Break

3:45 PM–4:00 PM	Birth Defect Categorization Systems Employed by Pregnancy Registries
	Covington DL, McKain LR, Hurst N. Pharmaceutical Product Development Inc., Wilmington, NC, United States.

4:00 PM–4:15 PM	Pregnancy Drug Safety Labeling and Surveillance at the Time of Product Approval
	McKain LF, Covington DL. Pharmaceutical Product Development, Inc., Wilmington, NC, United States.

4:15 PM–4:30 PM	Comparative Safety of Topiramate during Pregnancy
	Hernandez-Diaz S¹, Mittendorf R², Holmes LB³. ¹Harvard School of Public Health, Boston, MA, United States, ²Loyola University Chicago, Chicago, IL, United States, ³MassGeneral Hospital for Children, Boston, MA, United States.

4:30 PM–4:45 PM	UCB Antiepileptic Drug Pregnancy Registry
	Scheuerle A¹, Harden C², Alekar S³, Leppik I⁴, Montouris G⁵. ¹Tesserae Genetics, Dallas, TX, United States, ²University of Miami School of Medicine, Miami, FL, United States, ³UCB, Inc., Raleigh, NC, United States, ⁴University of Minnesota, Minneapolis, MN, United States, ⁵Boston University School of Medicine and Boston Medical Center, Boston, MA, United States.

4:45 PM–5:00 PM	Medication Exposure in Pregnancy Risk Evaluation Program
	Li DK¹, Andrade S², Scott P³, Cheetham C⁴, Cooper W⁵, Davis R⁶, Dublin S⁷, Pawloski P⁸, Raebel M⁹, Smith D¹⁰, Toh D¹¹. ¹Kaiser Permanente Northern California, Oakland, CA, United States, ²Meyers Primary Care Institute, Worcester, MA, United States, ³U.S. Food and Drug Administration, Silver Spring, MD, United States, ⁴Kaiser Permanente Southern California, Los Angeles, CA, United States, ⁵Vanderbilt University School of Medicine, Vanderbilt University School of Medicine, United States, ⁶Kaiser Permanente Georgia, Atlanta, GA, United States, ⁷Group Health Center for Health Studies,, Seattle, WA, United States, ⁸HealthPartners Research Foundation, Bloomington, MN, United States, ⁹Kaiser Permanente Colorado, Denver, CO, United States, ¹⁰Kaiser Permanente Northwest, Portland, OR, United States, ¹¹Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, United States.

5:00 PM–5:30 PM	Poster Session

1:30 PM–4:45 PM	Education Course Session 2 (Separate registration required)—Marriott Ballroom VI Postnatal Drug Disposition and Teratogenesis
	Organized by the Education Committee, Chairperson, Louise M. Winn, Queen’s University

1:30 PM–1:45 PM	Narsingh Agnish Fellowship
	Thomas H. Shepard, University of Washington

1:45 PM–2:15 PM	Lactational Transfer of Drugs
	Sue Marty, The Dow Chemical Company

2:15 PM–3:00 PM	Postnatal Metabolic Systems
	Ronald N. Hines, Medical College of Wisconsin

3:00 PM–3:15 PM	Break

3:15 PM–4:00 PM	Toxicity Profile Differences between Adults and Juveniles
	Melissa J. Beck, WIL Research Laboratories, LLC

4:00 PM–4:45 PM	Environmental Influences
	Carl L. Keen, University of California, Davis

6:00 PM–8:00 PM	Student/Postdoctoral Fellow Mixer—Champions Sport Bar


6:30 PM–9:30 PM	Council 1B Meeting and Committee Reports—Skybox Meeting Room